Avadel pharmaceuticals to present at the h.c. wainwright global investment conference

Dublin, ireland, may 18, 2022 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that greg divis, chief executive officer of avadel, will participate in a fireside chat at the h.c. wainwright global investment conference on wednesday, may 25 at 8:30 a.m. e.t.
AVDL Ratings Summary
AVDL Quant Ranking